- Home
- CTSO vs DXLG Comparison
CTSO vs DXLG Comparison
Compare CTSO & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- DXLG
- Stock Information
- Founded
- CTSO 1997
- DXLG 1976
- Country
- CTSO United States
- DXLG United States
- Employees
- CTSO N/A
- DXLG N/A
- Industry
- CTSO Medical/Dental Instruments
- DXLG Clothing/Shoe/Accessory Stores
- Sector
- CTSO Health Care
- DXLG Consumer Discretionary
- Exchange
- CTSO Nasdaq
- DXLG Nasdaq
- Market Cap
- CTSO 61.7M
- DXLG 55.4M
- IPO Year
- CTSO N/A
- DXLG 1987
- Fundamental
- Price
- CTSO $0.90
- DXLG $1.41
- Analyst Decision
- CTSO Buy
- DXLG Strong Buy
- Analyst Count
- CTSO 2
- DXLG 1
- Target Price
- CTSO $5.50
- DXLG $2.50
- AVG Volume (30 Days)
- CTSO 130.7K
- DXLG 216.3K
- Earning Date
- CTSO 11-06-2025
- DXLG 08-27-2025
- Dividend Yield
- CTSO N/A
- DXLG N/A
- EPS Growth
- CTSO N/A
- DXLG N/A
- EPS
- CTSO N/A
- DXLG N/A
- Revenue
- CTSO $36,107,520.00
- DXLG $447,744,000.00
- Revenue This Year
- CTSO $11.93
- DXLG N/A
- Revenue Next Year
- CTSO $21.22
- DXLG $3.56
- P/E Ratio
- CTSO N/A
- DXLG N/A
- Revenue Growth
- CTSO 20.18
- DXLG N/A
- 52 Week Low
- CTSO $0.71
- DXLG $0.90
- 52 Week High
- CTSO $1.61
- DXLG $3.10
- Technical
- Relative Strength Index (RSI)
- CTSO 42.05
- DXLG 56.66
- Support Level
- CTSO $0.87
- DXLG $1.20
- Resistance Level
- CTSO $1.04
- DXLG $1.52
- Average True Range (ATR)
- CTSO 0.05
- DXLG 0.08
- MACD
- CTSO -0.00
- DXLG 0.01
- Stochastic Oscillator
- CTSO 21.95
- DXLG 65.62
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.